Burns, M., Gaynor, K., Olm, V., Mercken, M., LaFrancois, J., Wang, L., Mathews, P.M., Noble, W., Matsuoka, Y. and Duff, K. 2003. Presenilin redistribution associated with aberrant cholesterol transport enhances b-amyloid production in vivo. J Neurosci. 23 : 5645-5649
Burns, M., Noble, W.J., Olm, V., Gaynor, K., Casey, L. and Duff, K.E., 2003. Co-localization of cholesterol, apolipoprotein E and fibrillar A-beta in amyloid plaques. Brain Res Mol Brain Res. 110:119-25
Burns, M. and Duff, K.E. Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease, 2003. Neurochem Res. 28:979-86.
Burns, M. and Duff, K. Intracellular cholesterol homeostasis and Alzheimer's disease, 2003. In: "Alzheimer's disease and related disorders: Research Advances" Iqbal, K. and Winblad, B. (eds). 559-567
Burns, M. and Duff, K.E. Cholesterol in Alzheimer's disease and tauopathy, 2002. Ann NY Acad Sci. 977, 367-376
Noble, W., Olm, V., Takata, K., Casey, K., O, M., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T., Davies, P., Burns, M., Matsuoka, Y., Ahlijanian, M., Lau, L-F., Duff, K. 2003. Hyperphosphorylation by CDK5 is a key pathogenic mechanism in tau aggregation and tangle formation. Neuron 38:555-565
Burns, M., Olm, V. and Duff, K.E. Apolipoprotein E, cholesterol and Alzheimer's disease, 2002. Neurobiology of Aging 23, S 401
Duff, K.E., Gaynor, K., Olm, V., Petanceska, S., Refolo, R. and Burns, M. Cholesterol in Alzheimer's disease, 2002. Neurobiology of Aging 23, S 567